| HOME >> BIOLOGY >> TECHNOLOGY |
HAMBURG, Germany, December 11 /PRNewswire/ --
- New 'Trophon EPR' Device Offers Unique Solution
Current methods of ultrasound transducer disinfection are in many cases not sufficient for clinical practice. This is the latest alarming result issued by the Center for Disease Control and Prevention (CDC), the leading US public health agency, in its recently published Guideline for Disinfection and Sterilization in Healthcare Facilities (1). The guideline is the CDC's response to the rapidly evolving epidemiology of hospital-acquired infections such as Clostridium Difficile (2) or MRSA (3).
In light of this global threat, and with regard to the millions of ultrasound examinations conducted each day, Nanosonics' newest product innovation represents a long-needed milestone in the development of medical devices: due to its unique technology, the Trophon EPR completely satisfies all requirements of the new CDC guideline.
Whereas current methods for high-level disinfection of contaminated transvaginal and transrectal transducers (e.g. aldehydes, alcohol or chlorine) show considerable drawbacks, the Trophon EPR has been custom designed to disinfect intracavity and surface ultrasound transducers, while combining speed, safety and convenience. It delivers high-level disinfection plus (HLD+), including sporicidal efficacy, in only six minutes operating time. The fully automated device can be used directly at the point of care, is easy to operate and is environmentally friendly, leaving water and oxygen as the only by-products.
"We recognised the danger presented by the inadequate disinfection of
ultrasound transducers, and know that the Trophon EPR will be indispensable
for the urgently needed hygiene necessary in the medical sector, to guarantee
the safety of each and every patient", explained David Radford, Director and
CEO of Nanosonics Limited, Australia, prior to the impending mar
'/>"/>
| SOURCE Nanosonics Europe GmbH Copyright©2008 PR Newswire. All rights reserved |